LILY34:BVMF
Eli Lilly And Company BDR
R$ १९५.६७
०.००%
(०.००) 1D
अक्टोबर ८, १७:०६:०० GMT-३ · BRL
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for LILY34...
Open
R$ १९९.७८
High
R$ १९९.७८
Low
R$ १८८.६०
Mkt. cap
११.०१ खरब
Avg. vol.
३६.६६ हजार
Volume
६२.६४ हजार
52-wk high
R$ २२३.०७
52-wk low
R$ १४१.५६
Shares outstanding
९४.१४ करोड
No. of employees
५० हजार
Open
R$ १९९.७८
High
R$ १९९.७८
Low
R$ १८८.६०
Mkt. cap
११.०१ खरब
Avg. vol.
३६.६६ हजार
Volume
६२.६४ हजार
52-wk high
R$ २२३.०७
52-wk low
R$ १४१.५६
Shares outstanding
९४.१४ करोड
No. of employees
५० हजार
News stories
From web sources and news partners
Investing.com
·
१ घण्टा पहिले
Lilly presents exploratory biomarker data from psoriasis study
Stock Titan
·
१ घण्टा पहिले
Lilly’s two medicines were linked to changes in 482 blood proteins, versus 140 with Taltz alone.
Seeking Alpha
·
३ घण्टा पहिले
Eli Lilly-backed TRexBio prices $117M US IPO at $14 per share (LLY:NYSE)
The Motley Fool
·
१९ घण्टा पहिले
Eli Lilly's Obesity Business Could Become a Much Bigger Healthcare Platform
Profile
Eli Lilly and Company, doing business as Lilly, is an American multinational pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries. Its products are sold in approximately 125 countries. The company was founded in 1876 by Eli Lilly, a pharmaceutical chemist and Union army veteran during the American Civil War for whom the company was later named.
The company is ranked 4th on the list of largest biomedical companies by revenue and is the most valuable pharmaceutical company worldwide. It is ranked 100th on the Fortune 500 and 138th on the Forbes Global 2000. In November 2025, the company reached a $1 trillion market capitalization, the first health-care company in the world to do so.
The company's primary products are tirzepatide for the treatment of type 2 diabetes, weight loss, and obstructive sleep apnea; abemaciclib for the treatment of advanced or metastatic breast cancers; dulaglutide for the treatment of type 2 diabetes; ixekizumab for the treatment of autoimmune diseases; and empagliflozin for the treatment of type 2 diabetes. Wikipedia
About Eli Lilly And Company BDR
CEODavid A. Ricks
Employees५० हजार
Founded१८७६
Headquartersइन्डियानापोलिस, इन्डियाना, संयुक्त राज्य अमेरिका
Sector-
Websitelilly.com